Postural change during venous blood collection is a major source of bias in clinical chemistry testing.
Author(s): Lippi G, Salvagno GL, Lima-Oliveira G, Brocco G, Danese E, Guidi GC
Publication: Clin Chim Acta, 2015, Vol. 440, Page 164-8
PubMed ID: 25437911 PubMed Review Paper? No
Purpose of Paper
This paper investigated if patient posture during blood draw affects levels of clinical chemistry analytes in serum and EDTA blood and also investigated if patient age, body mass index, height, weight, or gender influenced the effect of posture on plasma volume.
Conclusion of Paper
When compared to the quality specifications for bias, meaningful increases in hemoglobin, hematocrit, albumin, and total proteins and decreases in plasma volume were observed when the patient went from supine for 25 min to sitting for 20 min. In addition to the aforementioned increases and decreases, meaningful increases in alkaline phosphatase (ALP), total bilirubin, calcium, total and high density lipoprotein (HDL) cholesterol, glucose, and lactate dehydrogenase (LDH) occurred when the patient went from either supine or sitting to standing. Meaningful increases in amylase, aspartate aminotransferase (AST), gamma-glutamyl transferase (GGT), magnesium, and triglycerides occurred when the patient went from a supine to a standing position. Levels of chloride, C reactive protein (CRP), phosphate, sodium, potassium, and uric acid levels were not affected by patient posture and there was no effect of patient age, body mass index, gender, weight, or height on the bias in plasma volume.
Studies
-
Study Purpose
This study investigated if patient posture during blood draw affects levels of clinical chemistry analytes in serum and EDTA blood and also investigated if patient age, body mass index, height, weight, or gender influenced the effect of posture on plasma volume. Three fasting venous blood specimens were obtained from each of 19 healthy volunteers into serum vacuum tubes with clot activator and gel separator and K2EDTA vacuum tubes. The first specimen was drawn after the volunteer was supine for 25 min, the second after 20 minutes sitting, and the third after 20 min upright. Serum specimens were centrifuged at 1300 x g for 15 min and levels of albumin, ALP, alanine aminotransferase (ALT), alpha-amylase, AST, bilirubin total and conjugated, calcium, cholesterol total and HDL, chloride, creatine kinase (CK), creatinine, CRP, GGT, glucose, iron, LDH, lipase, magnesium, phosphate, potassium, total protein, sodium, triglycerides, urea, and uric acid were measured on a Cobas c501. Hematocrit and hemoglobin were measured in K2EDTA blood using an Advia 2120. The authors did not address the potential effects of sequential blood sampling on the results. The quality specifications for bias were based on biological variation.
Summary of Findings:
When the patient was sitting for 20 min before blood draw, the plasma volume was 3.4% lower than when the patient had been supine for 25 min and 9.7% higher than when the patients had been standing for 20 min. The effect of patient posture on plasma volume was not correlated with patient age, body mass index, gender, weight, or height. Compared to sitting patients, supine patients had statistically significantly lower levels of hemoglobin (-2.3%, P<0.001), hematocrit (-1.7%, P=0.009), albumin (-2.0%, P=0.001), ALP (-3.6%, P<0.001), ALT (-2.0%, P=0.035), amylase (-2.6%, P<0.001), AST (-4.5%, P=0.001), total cholesterol (-2.5%, P<0.001), HDL cholesterol (-3.1%, P<0.001), CK -2.5%, P<0.001), GGT (-4.2%, P=0.001), iron (-1.4%, P=0.008), LDH (-2.3%, P=0.045), magnesium (-1.4%, P=0.001), total protein (-2.9%, P=0.003), and triglycerides (-5.1%, P=0.021) and significantly higher levels of urea (1.4%, P=0.012), but only the biases in hemoglobin, hematocrit, albumin, and total proteins exceeded the quality specifications for bias. Compared to when sitting or supine, standing patients had significantly higher levels of hemoglobin (4.8%, P<0.001 and 7.1%, P<0.001, respectively), hematocrit (5.3%, P<0.001 and 6.9%, P<0.001, respectively), albumin (6.4%, P<0.001 and 10.3%, P<0.001, respectively), ALP (7.8%, P<0.001 and 11.1%, P<0.001, respectively), ALT (8.3%, P<0.001 and 9.1%, P<0.001, respectively), amylase (6.3%, P<0.001 and 8.7%, P<0.001, respectively), AST (5.6%, P=0.003 and 11.1%, P<0.001, respectively), conjugated bilirubin (6.2%, P=0.003 and 7.2%, P<0.001, respectively), total bilirubin (12.0%, P=0.001 and 13.3%, P<0.001, respectively), calcium (3.1%, P<0.001 and 3.4%, P<0.001, respectively), HDL cholesterol (5.7%, P<0.001 and 9.7%, P<0.001, respectively), total cholesterol (5.7%, P<0.001 and 8.9 %, P<0.001, respectively), CK (5.3%, P<0.001 and 8.0%, P<0.001, respectively), creatinine (1.4%, P=0.028 and 1.9 %, P=0.016, respectively), GGT (9.5%, P=0.002 and 11.1%, P<0.001, respectively), glucose(3.8%, P=0.022 and 5.4%, P=0.001, respectively), iron (5.2%, P=0.015 and 7.0%, P=0.002, respectively), LDH (7.2%, P=0.001 and 9.8 %, P<0.001, respectively), lipase (4.0%, P=0.004 and 3.4%, P=0.016, respectively), magnesium (P=0.197 and 3.5%, P<0.001, respectively), total protein (8.0%, P<0.001 and 10.7%, P<0.001, respectively), and triglycerides(6.6%, P=0.002 and 11.5%, P<0.001, respectively), and significantly lower levels of urea (-1.9%, P=0.005 and -3.1%, P<0.001, respectively). However, when compared to the quality specifications for bias, the differences in hemoglobin, hematocrit, albumin, ALP, total bilirubin, calcium, total and HDL cholesterol, glucose, LDH, and total protein between sitting or supine and standing were considered meaningful. Additionally, the difference in levels of amylase, AST, GGT, magnesium, and triglycerides between supine and standing were considered meaningful. Levels of chloride, CRP, phosphate, sodium, potassium, and uric acid levels were not affected by patient posture.
Biospecimens
Preservative Types
- None (Fresh)
Diagnoses:
- Normal
Platform:
Analyte Technology Platform Carbohydrate Clinical chemistry/auto analyzer Electrolyte/Metal Clinical chemistry/auto analyzer Cell count/volume Clinical chemistry/auto analyzer Steroid Clinical chemistry/auto analyzer Protein Clinical chemistry/auto analyzer Small molecule Clinical chemistry/auto analyzer Lipid Clinical chemistry/auto analyzer Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Biospecimen Acquisition Patient posture Sitting
Standing
Supine
Biospecimen Aliquots and Components Aliquot sequential collection 1st collection
2nd collection
3rd collection
Preaquisition Patient body mass index Mean height 1.68 ± 0.11 m and Mean weight 68 ± 12 kg
Preaquisition Patient age 44±11 years
Preaquisition Patient gender Female
Male
